Literature DB >> 17985382

The effect of thrombectomy on myocardial blush in primary angioplasty: the Randomized Evaluation of Thrombus Aspiration by two thrombectomy devices in acute Myocardial Infarction (RETAMI) trial.

Gennaro Sardella1, Massimo Mancone, Bich Lien Nguyen, Leonardo De Luca, Angelo Di Roma, Riccardo Colantonio, Alessandro Petrolini, Giulia Conti, Francesco Fedele.   

Abstract

BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI), primary percutaneous coronary intervention (PCI) may cause thrombus dislodgment leading to microvascular function impairment, which is a negative independent predictor of myocardial function recovery. Compared with conventional stenting, pretreatment with aspiration thrombectomy during primary PCI significantly improves coronary epicardial flow and myocardial tissue perfusion parameters. We sought to evaluate the angiographic findings of two different manual aspiration thrombectomy devices (Diver-Invatec (DI) and Export-Medtronic (EM)) in STEMI patients undergoing primary angioplasty.
METHODS: We randomized 103 STEMI patients referred to our hospital to undergo primary PCI (<12 hr from symptoms onset) to DI (n = 52) and EM (n = 51) devices. The primary angiographic composite end-points were the rates of post-thrombectomy thrombus score (TS) < or =2, TIMI flow grade > or =2, and post-stenting myocardial blush grade (MBG) > or =2 in the two groups.
RESULTS: Baseline, clinical, and angiographic preprocedural findings did not differ between the two groups. After aspiration thrombectomy, a TS < or = 2 was more frequently present in EM group (92.3 vs. 69.3%, P = 0.0052). Also the rate of post-thrombectomy TIMI > or = 2 (69.3 vs. 92.2%, P = 0.0052) and post-stenting MBG > or =2 (88.2 vs. 69.3%, P = 0.029) were significantly higher in EM group. No significative differences were observed in terms of clinical events at 1 and 12 months.
CONCLUSIONS: In this single-center, prospective, randomized study, a EM use before stenting in STEMI patients seems to remove more thrombotic burden compared with DI, providing a greater post-thrombectomy epicardial flow and a better post-stenting microvascular perfusion. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17985382     DOI: 10.1002/ccd.21312

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Manual vs mechanical thrombectomy during PCI for STEMI: a comprehensive direct and adjusted indirect meta-analysis of randomized trials.

Authors:  Eliano Pio Navarese; Giuseppe Tarantini; Giuseppe Musumeci; Massimo Napodano; Roberta Rossini; Mariusz Kowalewski; Anna Szczesniak; Michalina Kołodziejczak; Jacek Kubica
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

Review 2.  Thrombus aspiration in acute myocardial infarction: Rationale and indication.

Authors:  Gennaro Sardella; Rocco Edoardo Stio
Journal:  World J Cardiol       Date:  2014-09-26

3.  Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials.

Authors:  Umesh U Tamhane; Stanley Chetcuti; Irfan Hameed; P Michael Grossman; Mauro Moscucci; Hitinder S Gurm
Journal:  BMC Cardiovasc Disord       Date:  2010-02-26       Impact factor: 2.298

4.  ST-elevation myocardial infarction, thrombus aspiration, and different invasive strategies. A TASTE trial substudy.

Authors:  Ole Fröbert; Fredrik Calais; Stefan K James; Bo Lagerqvist
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

5.  Angiographic and Clinical Impact of Successful Manual Thrombus Aspiration in Diabetic Patients Undergoing Primary PCI.

Authors:  Mohamed Shehata
Journal:  Int J Vasc Med       Date:  2014-04-02

6.  Manual Thrombus Aspiration and the Improved Survival of Patients With Unstable Angina Pectoris Treated With Percutaneous Coronary Intervention (30 Months Follow-Up).

Authors:  Bekir S Yildiz; Murat Bilgin; Mustafa Zungur; Yusuf I Alihanoglu; Ismail D Kilic; Ipek Buber; Ahmet Ergin; Havane A Kaftan; Harun Evrengul
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.